Differential regulation of constitutive major histocompatibility complex class I expression in T and B lymphocytes

Journal of Experimental Medicine

Volumn 190, Issue 10, 1999, Pages 1451-1463

  Lee, Chien Kuo ^a   Gimeno, Ramon ^a   Levy, David E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene regulation; Interferon; Interleukin 7; STAT1; Tyrosine phosphorylation

Indexed keywords

INTERFERON RECEPTOR; INTERLEUKIN 7; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; STAT1 PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; GENE CONTROL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CELL NUCLEUS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERONS; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTO-ONCOGENES; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0033571762     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.10.1451     Document Type: Article

References (76)

1. David-Watine, B., A. Israël, and P. Kourilsky. 1990. The regulation and expression of MHC class I genes. Immunol. Today. 11:286-292.
2. Ozato, K., Y.-J. Wan, and B. Orrison. 1985. Mouse major histocompatibility class I gene expression begins at midsoniite stage and is inducible in earlier-stage embryos by interferon. Prof. Natl. Acad. Sci. USA. 82:2427-2431.
3. Jaffe, L., J. Jeannotte, E.K. Bikoff, and E.J. Robertson. 1990. Analysis of β2-microglobulin gene expression in the developing mouse embryo and placenta. J. Immunol. 145:3474-3482.
4. Drezen, J.M., P. Nouvel, C. Babinet, and D. Morello. 1992. Different regulation of class I gene expression in the adult mouse and during development. J. Immunol. 149:429-437.
5. Segars, J.H., T. Nagata, V. Bours, J.A. Medin, G. Franzoso, J.C. Blanco, P.D. Drew, K.G. Becker, J. An, and T. Tang. 1993. Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-kappa B (p50-p65) and retinoic acid receptor beta-retinoid X receptor beta heterodimers. Mol. Cell. Biol. 13:6157-6169.
6. Delaney, J.R., Y. Sykulev, H.N. Eisen, and S. Tonegawa. 1998. Differences in the level of expression of class I major histocompatibility complex proteins on thymic epithelial and dendritic cells influence the decision of immature thymocytes between positive and negative selection. Proc. Natl. Acad. Sci. USA. 95:5235-5240.
7. Ting, J.P., and A.S. Baldwin. 1993. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:8-16.
8. Girdlestone, J. 1996. Transcriptional regulation of MHC class I genes. Eur. J. Immunogenet. 23:395-413.
9. Israel, A., A. Kimura, M. Kieran, O. Yano, J. Kanellopoulus, B.O. Le, and P. Kourilsky. 1987. A common positive trans acting factor binds to enhancer sequences in the promoters of mouse H-2 and β2-microglobulin genes. Proc. Natl. Acad. Sci. USA. 84:2653-2657.
10. Shirayoshi, Y., J.I. Miyazaki, P.A. Burke, K. Hamada, E. Appella, and K. Ozato. 1987. Binding of multiple nuclear factors to the 5′ upstream regulatory element of the murine major histocompatibility class I gene. Mol. Cell. Biol. 7:4542-4548.
11. Johnson, D.R., and J.S. Pober. 1994. HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol. Cell. Biol. 14: 1322-1332.
12. Martin, B.K., K.C. Chin, J.C. Olsen, C.A. Skinner, A. Dey, K. Ozato, andJ.P. Ting. 1997. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity. 6:591-600.
13. Gobin, S.J., A. Peijnenburg, V. Keijsers, and P.J. van den Elsen. 1997. Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity. 6:601-611.
14. York, I.A., and K.L. Rock. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369-396.
15. Lehner, P.J., and P. Cresswel. 1996. Processing and delivery of peptides presented by MHC class I molecules. Curr. Opin. Immunol. 8:59-67.
16. Gaczynska, M., K.L. Rock, and A.L. Goldberg. 1993. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature. 365:264-267.
17. Van Kaer, L., P.G. Ashton-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K.L. Rock, A.L. Goldberg, P.C. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity. 1:533-541.
18. Fehling, H.J., W. Swat, C. Laplace, R. Kuhn, K. Rajewsky, U. Muller, and H. von Boehmer. 1994. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science. 265:1234-1237.
19. Neefjes, J.J., F. Momburg, and G.J. Hammerling. 1993. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science. 261:769-771.
20. Attaya, M., S. Jameson, C.K. Martinez, E. Hermel, C. Aldrich, J. Forman, K.F. Lindahl, M.J. Bevan, and J.J. Monaco. 1992. Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature. 355:647-649.
21. Meraz, M.A., M.J. White, K.C.F. Sheehan, E.A. Bach, S.J. Rodig, A.S. Dighe, D.H. Kaplan, J.K. Riely, A.C. Greenlund, D. Campbell, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 84:431-442.
22. Müller, M., C. Laxton, J. Briscoe, C. Schindler, T. Improta, J.E. Darnell, G.R. Stark, and I.M. Kerr. 1993. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO (Eur. Mol. Biol. Organ.) J. 12: 4221-4228.
23. Levy, D.E., D.S. Kessler, R. Pine, N. Reich, and J.E. Darnell. 1988. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative control. Genes Dev. 2:383-393.
24. Matsuyama, T., T. Kimura, M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T.M. Kündig, R. Amakawa, K. Kishihara, A. Wakeham, et al. 1993. Targeted disruption of IRF-1 and IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell. 75:83-97.
25. Stark, G.R., I.M. Kerr, B.R. Williams, R.H. Silverman, and R.D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
26. Darnell, J.E. 1997. STATs and gene regulation. Science. 271: 1630-1635.
27. Ihle, J.N. 1996. STATs: signal transducers and activators of transcription. Cell. 84:331-334.
28. Sahni, M., D.C. Ambrosetti, A. Mansukhani, R. Gertner, D.E. Levy, and C. Basilico. 1999. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the Stat1 pathway. Genes Dev. 13:1361-1366.
29. Akashi, K., M. Kondo, and I.L. Weissman. 1998. Role of interleukin-7 in T-cell development from hematopoietic stem cells. Immunol. Rev. 165:13-28.
30. von Freeden-Jeffry, U., P. Vieira, L.A. Lucian, T. McNeil, S.E. Burdach, and R. Murray. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1519-1526.
31. Peschon, J.J., P.J. Morrissey, K.H. Grabstein, F.J. Ramsdell, E. Maraskovshy, B.C. Gliniak, L.S. Park, S.F. Ziegler, D.E. Williams, and C.B. Ware. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180:1955-1960.
32. Lin, J.-X-, T.-S. Migone, M. Tsang, M. Friedmann, J.A. Weatherbee, L. Zhou, A. Yamauchi, E.T. Bloom, J. Mietz, S. John, et al. 1995. The role of shared receptor motifs and common stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity. 2:331-339.
33. van der Plas, D.C., F. Smiers, K. Pouwels, L.H. Hoefsloot, B. Löwenberg, and I.P. Touw. 1996. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor α chain. Leukemia. 10:1317-1325.
34. Maraskovshy, E., M. Teepe, P.J. Morrissey, S. Braddy, R.E. Miller, D.H. Lynch, and J.J. Peschon. 1996. Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells. J. Immunol. 157:5315-5323.
35. Costello, R.T., F. Mallet, H. Chambost, D. Sainty, J. Gastaut, and D. Olive. 1999. Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias. Eur. Cytokine Netw. 10:87-95.
36. Durbin, J.E., R. Hackenmiller, M.C. Simon, and D.E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 84: 443-450.
37. Müller, U., U. Steinhoff, L.F.L. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264: 1918-1921.
38. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science. 259:1742-1745.
39. Riley, J.K., K. Takeda, S. Akira, and R.D. Schreiber. 1999. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J. Biol. Chem. 274:16513-16521.
40. Maniatis, T., E. Fritsh, and J. Sambrook. 1989. Molecular Cloning. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
41. Pear, W., G. Nolan, M. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:8392-8396.
42. Schwaller, J., J. Frantsve, J. Aster, I.R. Williams, M.H. Tomasson, T.S. Ross, P. Peeters, L. van Rompaey, R.A. van Etten, R. Ilaria, Jr., et al. 1998. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO (Eur. Mol. Biol. Organ.) J. 17:5321-5333.
43. Lee, C.-K., H.A.R. Bluyssen, and D.E. Levy. 1997. Regulation of interferon-α responsiveness by the duration of Janus kinase activity. J. Biol. Chem. 272:21872-21877.
44. Silvennoinen, O., C. Schindler, J. Schlessinger, and D.E. Levy. 1993. Ras-independent signal transduction in response to growth factors and cytokines by tyrosine phosphorylation of a common transcription factor. Science. 261:1736-1739.
45. Revel, M., and J. Chebath. 1986. Interferon-activated genes. Trends Biochem. Sci. 11:166-170.
46. Baeuerle, P.A., M.J. Lenardo, J.W. Pierce, and D. Baltimore. 1988. Phorbol-ester-induced activation of the NF-κB transcription factor involves dissociation of an apparently cytoplasmic NF-κB/inhibitor complex. Cold Spring Harb. Symp. Quant. Biol. 53:789-798.
47. Baldwin, A.S.J. 1996. The NF kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14: 649-683.
48. Baeuerle, P.A., and D. Baltimore. 1996. NF-kappa B: ten years after. Cell. 87:13-20.
49. Hobart, M., V. Ramassar, N. Goes, J. Urmson, and P.F. Halloran. 1997. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J. Immunol. 158:4260-4269.
50. Drezen, J.M., C. Babinet, and D. Morelo. 1993. Transcriptional control of MHC class I and β2-microglobulin genes in vivo. J. Immunol. 150:2805-2813.
51. Zheng, P., Y. Guo, Q. Niu, D.E. Levy, J.A. Dyck, S. Lu, L.A. Sheiman, and Y. Liu. 1998. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature. 396:373-376.
52. Hofmeister, R., A.R. Khaled, N. Benbemou, E. Rajnavolgyi, K. Muegge, and S.K. Durum. 1999. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev. 10:41-60.
53. Muegge, K., M.P. Vila, and S.K. Durum. 1993. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor β gene. Science. 261:93-95.
54. Corcoran, A.E., A. Riddell, D. Krooshoop, and A.R. Venkitaraman. 1998. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature. 391:904-907.
55. Sudo, T., S. Nishikawa, N. Ohno, N. Akiyama, M. Tamakoshi, H. Yoshida, and S. Nishikawa. 1993. Expression and function of the interleukin 7 receptor in munne lymphocytes. Proc. Nad. Acad. Sci. USA. 90:9125-9129.
56. Rodig, S.J., M.A. Meraz, J.M. White, P.A. Lampe, J.K. Riley, C.D. Arthur, K.L. King, C.F. Sheehan, L. Yin, D. Pennica, et al. 1998. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell. 93:373-383.
57. Nosaka, T., J. van Deursen, R.A. Tripp, W.E. Thierfelder, B.A. Witthuhn, A.P. McMickle, P.C. Doherty, G.C. Grosveld, and J.N. Ihle. 1995. Defective lymphoid development in mice lacking Jak3. Science. 270:800-802.
58. Moriggl, R., D.J. Topham, S. Teglund, V. Sexl, C. McKay, D. Wang, A. Hoffmeyer, J. van Deursen, M.Y. Sangster, K.D. Bunting, et al. 1999. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity. 10:249-259.
59. Pallard, C., A.P. Stegmann, T. van Kleffens, F. Smart, A. Venkitaraman, and H. Spits. 1999. Distinct roles of the phosphatidylinositol 3-kinase and STATS pathways in IL-7-mediated development of human thymocyte precursors. Immunity. 10:525-535.
60. O'Shea, J.J. 1997. Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity. 7:1-11.
61. Sampath, D., M. Castro, D.C. Look, and M.J. Holtzman. 1999. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma. J. Clin. Invest. 103:1353-1361.
62. Tovey, M.G., M. Streuli, I. Gresser, J. Gugenheim, B. Blanchard, J. Guymarho, F. Vignaux, and M. Gigou. 1987. Interferon mRNA is produced constitutively in the organs of normal individuals. Pror. Natl. Acad. Sci. USA. 84:5038-5042.
63. Starr, R., D. Metcalf, A.G. Elefanty, M. Brysha, T.A. Willson, N.A. Nicola, D.J. Hilton, and W.S. Alexander. 1998. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA. 95:14395-14399.
64. Alexander, W.S., R. Starr, J.E. Fenner, C.L. Scott, E. Handman, N.S. Spriggs, J.E. Corbin, A.L. Cornish, R. Darwiche, C.M. Owczarek, et al. 1999. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell. 98:597-608.
65. Harada, H., T. Taniguchi, and N. Tanaka. 1998. The role of interferon regulatory factors in the interferon system and cell growth control. Biochimie. 80:641-650.
66. Marié, I., J.E. Durbin, and D.E. Levy. 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO (Eur. Mol. Biol. Organ.) J. 17:6660-6669.
67. + thymocytes. Immunity. 7:243-254.
68. -/- mice. Immunity. 5:365-376.
69. Ploegh, H.L. 1998. Viral strategies of immune evasion. Science. 280:248-253.
70. Ahn, K., A. Angulo, P. Ghazal, P.A. Peterson, Y. Yang, and K. Fruh. 1996. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA. 93:10990-10995.
71. Ziegler, H., R. Thale, P. Lucin, W. Muranyi, T. Flohr, H. Hengel, H. Farrell, W. Rawlinson, and U.H. Koszinowski. 1997. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity. 6:57-66.
72. Paabo, S., L. Severinsson, M. Andersson, I. Martens, T. Nilsson, and P.A. Peterson. 1989. Adenovirus proteins and MHC expression. Adv. Cancer Res. 52:151-163.
73. Schwartz, O., V. Marechal, S. Le Gall, F. Lemonnier, and J.M. Heard. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2:338-342.
74. Miller, D.M., B.M. Rahill, J.M. Boss, M.D. Lairmore, J.E. Durbin, W.J. Waldman, and D.D. Sedmak. 1998. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187:675-683.
75. Look, D.C., W.T. Roswit, A.G. Frick, Y. Gris-Alevy, D.M. Dickhaus, M.J. Walter, and M.J. Holtzman. 1998. Direct suppression of Stat1 function during adenovirus infection. Immunity. 9:871-880.
76. Garcia-Sastre, A., R.K. Durbin, H. Zheng, P. Palese, R. Gertner, D. Levy, and J.E. Durbin. 1998. The role of interferon in influenza virus tissue tropism. J. Virol. 72:8550-8558.